This report is an overview of our research on phytochemical, synthetic and biological studies of the Stemona and Stichoneuron species of plants.
This paper is a summary of the invited lecture presentation by Stephen Pyne at the ISNPF2016 conference at Tokushima in September 2016. Extracts of the roots of the Stemona species of plants have been used in traditional medicine to treat the symptoms of bronchitis, pertussis and tuberculosis and have been used as antiparasitics on humans and animals ( Figure 1 ) [1] . Some of the pure alkaloids derived from these plants have significant antitussive activity in guinea pig after cough induction [1, 2] as well as insect toxicity, anti-feedant and repellent activities [3, 4] . The Stemona group of alkaloids includes more than 130 unique natural products which have been structurally classified into six different groups [1] . The pyrrolo[1,2-a]azepine (5,7-bicyclic A,Bring system) nucleus is common to all compounds in five of these groups (croomine (1) for example in Figure 2 ). In 2003 we [3] and then Greger [4] reported the structures of Stemona alkaloids with a pyrido[1,2-a]azepine A,B-ring system (6,7-bicyclic A,B-ring system), including stemocurtisine 2. These alkaloids now comprise the sixth structural group (the stemocurtisine group).
Certain Stemona alkaloids have oxytocin antagonistic effects [5] , the ability to inhibit nitric oxide production [6] , have P-glycoprotein (P-gp)-modulation effects [7] and are inhibitors of acetylcholinesterase AChE [8] , a property associated with insecticidal activity [9] . We have reported that the Stemona alkaloids stemofoline and 11(Z)-1',2'-didehydrostemofoline, and some of their synthetic derivatives, inhibit P-gp-mediated drug resistance in cancer cell lines [ [3] . Its structure was unequivocally determined by singlecrystal X-ray analysis ( Figure 2 ) [3] . In the same year Greger [4] reported the isolation of 2, and a new pyrido[1,2-a]azepine alkaloid, oxystemokerrin 3 ( Figure 2 ). In 2004 we disclosed the structure of another pyrido[1,2-a]azepine alkaloid, stemocurtisinol 4 [12] . Greger [4] and shortly after our group [12] also published the isolation of oxyprotostemonine 5, a pyrrolo[1,2a]azepine alkaloid ( Figure 2 ). Compounds 2, 4 and 5 had significant larvicidal activity on malaria-carrying mosquito larvae (Anopheles minimus HO) [12] . Subsequent studies by our group of the extracts of Stemona curtisii Hook. f. from Trang Provence identified two other new natural products, 6-hydroxy-5,6-seco-stemocurtisine 6 [13] , the only know seco-pyrido[1,2-a]azepine alkaloid to date, and 1-hydroxyprotostemonine 7 (Figure 3 ) [14] . A. Prof. Jatisatienr and Dr. Mungkornasawakul further developed the crude extracts of Stemona curtisii into a biopesticide formulation which showed promise in field trials as an anti-feedant on Chinese cabbage and other commercial vegetable crops ( Figure 4 ).
In 2009 we reported the isolation and structure determination of two novel Stemona alkaloids, stemaphylline (8) and stemaphylline-Noxide (9), from the root extracts of Stemona aphylla which was collected at Mae Hong Son, Thailand ( Figure 5 ) [15] . The insecticidal activity of 8 was determined using a topical application assay against Plutella xylostella. Compound 8 had insecticidal activity very similar (LC 50 1,824 µg/mL) to the positive control (methomyl, LC 50 1,840 µg/mL). Our study of the root extracts of S. aphylla, collected in Lampang Province, Thailand, at a location different from that of our abovementioned study on this plant species resulted in the identification of a new stemofoline alkaloid. This was (2′S)hydroxy-11(S),12(R)-dihydrostemofoline 12 which was isolated along with six new stemofurans and the known compounds stemofoline (10) and (2′S)-hydroxystemofoline (11) [ Figure 6 ] [16] . (2′S)-Hydroxy-11(S),12(R)-dihydrostemofoline 12 was significantly less active as an AChE inhibitor than stemofoline (10) itself, perhaps due to the lack of rigidity of the C-11-C-12 double bond. In 2008 Kwankamol Sastraruji, a graduate from CMU, joined my laboratory as a PhD student. She brought with her extracts of an unidentified Stemona sp. rich in 11(Z)-1',2'-didehydrostemofoline 13. From 935 g of the dry root we could isolate 6 g of 11(Z)-1',2'didehydrostemofoline 13 after purification by column chromatography. This compound served as a starting material to prepare a library of derivatives and analogues around the aldehyde 15 (Scheme 1) and the alkyne derivative 16 (Scheme 2) using, reductive amination ( These derivatives were screened as inhibitors against AChE and P-gp. There is current interest in AChE inhibitors for the treatment of Alzheimer's disease (AD) [17] . These inhibitors act by increasing the acetylcholine concentration in the brain which helps improve cognitive, behavioural and functional impairments. Reversible AChE inhibitors, for example the alkaloid galanthamine (Reminyl), have been used in the treatment of patients with AD to alleviate the symptoms associated with this disease [18] . Unfortunately, these inhibitors are not a cure for AD and do not stop progression of the disease. Current drug development strategies involve targeting microtubule-associated -protein, metal ion dyshomeostasis and the various -amyloid (A) pathological mechanisms of this disease [18, 19] . The finding that AChE colocalizes with A and promotes and accelerates A aggregation [20] [21] [22] has renewed an intense interest in AChE inhibitors, including dual binding AChE inhibitors [23] and those that can be activated by AChE [24] and have Aanti-aggregating action. The identification of new AChE inhibitors is therefore of importance for new applications in both agriculture and medicine.
Unfortunately the AChE inhibitory activities of our compounds were at best modest with IC 50 values > 12 M against electric eel (ee) AChE and IC 50 values > 19 M against human (h) AChE, Table 1 , entry 3, far less than that of galanthamine (entry 1) with IC 50 values of 0.9 and 0.6 M, respectively in our in-house assay. The most potent compound being a synthetic amine derivative, the structure of this compound is shown in Table eserine as a reference compound. Compound 13 showed the highest inhibitory activity of AChE with a minimum inhibitory quantity of 5 ng, followed by compound (3'S)-24 at 10 ng. The (3'R)diastereomer of 24 was less active than (3'S)-24 with a minimum inhibitory quantity of 100 ng [11(a)]. In collaboration with A. Prof. Pornngarm Limtrakul (Biochemistry, CMU) a number of Stemona alkaloids and their synthetic derivatives have been studied for their abilities to inhibit P-gpmediated drug resistance in cancer cell lines [10] . P-glycoprotein is responsible for the efflux of chemotherapeutic drugs from cancer cells and its overexpression is one of the mechanisms of drug resistance. We have identified several compounds that reverse multi-drug resistance (MDR) to important clinically used drugs (e.g. vinblastine and doxorubicin) in drug-resistance human cervical carcinoma (KB-V1) and human leukemic (K562/Adr) cell lines that overexpress P-gp. It was also demonstrated that these compounds inhibit P-gp function. As shown in Table 2 , the IC 50 for vinblastine against a drug-sensitive human cervical carcinoma (KB-3-1) is 0.61 nM but against a drug-resistance human cervical carcinoma (KB-V1 (MDR)) vinblastine is 1000 fold less potent (IC 50 = 0.6 M). However in the presence of 11(Z)-1',2'-didehydrostemofoline 13 and stemofoline 10 and their synthetic analogues (25 and 26) the IC 50 of vinblastine is significantly enhanced (3-7 fold) against KB-V1 (MDR (Table 2 (a) ). The most effective compound was stemofoline 10 which enhanced the potency of vinblastine by 7 fold [10]. In the case of drug resistance human leukemic (K562/Adr (MDR)), we found that the most effective compound was the synthetic analogue 25 which enhanced the potency of doxorubicin by 7 fold followed by stemofoline 10 which enhanced the potency of doxorubicin by 4 fold ( (Figure 8 ) having a novel tetrahydrofuran ring and sessillistemoamines E and F (structures not shown) [27] . From the extracts of Stichoneuron halabalensis, also growing in Peninsula Malaysia, three new alkaloids, stichoneurines C −E were isolated ( Figure 8 ) [28] . One can imagine that all seven stichoneurine alkaloids could be biosynthetically related through different redox pathways.
We are also interested in the total synthesis of Stemona alkaloids [29, 30] . Our recent strategy for the synthesis of stemocurtisine 2 (Figure 2 ) was based on the premise that the synthetically challenging bridging ketal moiety of this compound could be realized via a photochemically induced oxidative cyclization reaction of the tricyclic alcohol 29 (Scheme 3). We proposed that this reaction would proceed via H-atom abstraction at C-3a by the generated C-11 alkoxy radical. However, irradiation of a solution of racemic 29, I 2 and PhI(OAc) 2 led only to the aldehyde product 30, formed by oxidative cleavage of the A-ring [29] . None of the desired product 31 was isolated.
In conclusion, the Stemona and Stichoneuron species of plants have and continue to produce alkaloids having novel chemical structures and biological activities. The root extracts, and their associated alkaloids and their synthetic analogues show potential applications in agriculture as anti-feedants and insecticides and in medicine as AChE and P-gp inhibitors. New biotechnology methods of producing these alkaloids in larger quantities are required to progress this area further.
